Novel Applications of Thiosuccinyl-Crosslinked Hemoglobin Conjugates

Publication ID: 24-11857605_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Novel Applications of Thiosuccinyl-Crosslinked Hemoglobin Conjugates,” Published Technical Disclosure No. 24-11857605_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857605_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,605.

Summary of the Inventive Concept

This inventive concept leverages the core technology of thiosuccinyl-crosslinked hemoglobin conjugates to address various unmet needs in industries beyond pharmaceuticals, including agricultural pest control, bioremediation, cosmetics, environmental monitoring, and food processing.

Background and Problem Solved

The original patent disclosed thiosuccinyl-crosslinked hemoglobin conjugates for pharmaceutical applications, but their potential extends far beyond. This inventive concept addresses the limitations of existing solutions in other industries, where the conjugates' unique properties can provide significant benefits.

Detailed Description of the Inventive Concept

The new claims describe systems and methods that utilize thiosuccinyl-crosslinked hemoglobin conjugates in novel applications. For example, in agricultural pest control, the conjugate can deliver pesticides to targeted areas, reducing environmental impact. In bioremediation, the conjugate can bind to heavy metals, facilitating their removal from contaminated sites. Similarly, the conjugate can be used in cosmetics to deliver active ingredients to the skin, in environmental monitoring to detect pollutants, and in food processing to extend product shelf life.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of thiosuccinyl-crosslinked hemoglobin conjugates, moving beyond pharmaceuticals to address unmet needs in various industries. This inventive concept is non-obvious because it requires a deep understanding of the conjugates' properties and their potential to solve real-world problems in diverse fields.

Alternative Embodiments and Variations

Other embodiments of this inventive concept could include using different types of polymers or linkers, varying the molecular weight of the conjugate, or exploring alternative methods of administration or detection. These variations could further expand the conjugates' potential in various industries.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential, as it addresses pressing needs in multiple industries. The market for these applications is substantial, with potential customers including agricultural companies, bioremediation service providers, cosmetics manufacturers, environmental monitoring agencies, and food processing companies.

CPC Classifications

SectionClassGroup
A A61 A61K38/42
A A61 A61K47/542
A A61 A61K47/545
A A61 A61K47/60
A A61 A61P9/10

Original Patent Information

Patent NumberUS 11,857,605
TitleThiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof
Assignee(s)Billion King International Limited